Insights from 2023 ESMO Asia Annual Meeting

 

Insights from 2023 ESMO Asia Annual Meeting
N

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent Clear Cell Gynecological Cancer

By Insights from 2023 ESMO Asia Annual Meeting FEATURING Natalie Ngoi
By Insights from 2023 ESMO Asia Annual Meeting FEATURING Natalie Ngoi
178 views
February 13, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Gynecologic
05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi